X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/moberg-pharma-has-completed-enrollment-to-the-phase-3-study-for-mob-015-in-north-america-301949250.html
https://www.prnewswire.com/news-releases/moberg-pharma-and-padagis-sign-agreement-for-mob-015-in-israel-301599703.html
https://www.prnewswire.com/news-releases/moberg-pharma-enters-into-collaboration-with-allderma-for-launch-in-scandinavia-301418276.html
https://www.prnewswire.com/news-releases/moberg-pharma-receives-approval-from-the-emas-paediatric-committee-301382355.html
https://www.prnewswire.com/news-releases/moberg-pharma-decides-on-fully-guaranteed-rights-issue-of-approximately-sek-150-million-301167754.html
https://www.prnewswire.com/news-releases/moberg-pharma-intends-to-distribute-and-separately-list-bupizenge-bupi-301167753.html
https://www.pharmacompass.com/pdf/news/moberg-pharma-decides-on-fully-guaranteed-rights-issue-of-approximately-sek-150m-1606298316.pdf
https://www.prnewswire.com/news-releases/moberg-pharma-intends-to-submit-a-registration-application-in-europe-in-2021-301151853.html
https://www.prnewswire.com/news-releases/moberg-pharma-meets-primary-endpoint-in-the-european-phase-3-study-301083457.html
https://www.prnewswire.com/news-releases/expert-evaluation-clarifies-phase-3-results-and-provides-strong-support-for-mob-015-300990988.html
Market Place
Share 
